More than 20 U.S. National Laboratory Payloads Part of SpaceX’s 16th Mission to Space Station
KENNEDY SPACE CENTER (FL), November 27, 2018 – SpaceX is targeting no earlier than December 4 at 1:38 p.m. EST…
ISS360: The ISS National Lab Blog
Studying Plant Growth in Microgravity and on the Moon
For the first time, a plant sprouted on the moon! As part of China's Chang'e-4 mission, which landed on the far side of the…
Designing Better Drugs: Piecing Together Protein Function Through Structure
Proteins—large molecules made up of hundreds to thousands of amino acids—are vital to the proper function of tissues and organs in our body. Each…
SpaceX's Dragon Returns Valuable Research to Earth
Yesterday at 6:33 p.m. EST, the SpaceX Dragon spacecraft was released from the International Space Station (ISS), sending it on its way back to…
Advancing Parkinson's Research in Space
During her first interview from space earlier this week, NASA astronaut Anne McClain spoke with students at Kranz Junior High School in Dickinson, Texas.…
Using the Excitement of Space to Engage Girls in Science
This Sunday, NBC Nightly News, which airs at 6:30 p.m. Eastern Time, is expecting to feature…
Expanding the ISS National Lab R&D Portfolio
Fiscal year 2018 (FY18) was a banner year for expansion of the International Space Station (ISS)…
Investment Perspectives: Snapshots from the ISS National Lab FY18 Annual Report
The International Space Station (ISS) U.S. National Laboratory has published its fiscal year 2018 (FY18, September…
Stay Informed
New ISS National Lab Research Aims to Treat Blindness
LambdaVision is a startup company who is developing a retinal implant that has the capacity to treat retinal degenerative blindness, which affects millions around the world. By sending research to the International Space Station (ISS) U.S. National Laboratory, LambdaVision seeks to improve the manufacturing process associated with this implant.
Mission MIC: What Makes Ecolab Leaders in Microbial Control?
Mission MIC is a collaboration between Ecolab and the ISS National Lab that will enable us to study how oilfield biofilms grow in zero gravity versus what we see on earth. The experiment will launch in December 2018 and will help us answer questions that affect oilfield microbiology today.
ISS National Lab NG-10 Research Spotlight: Microfluidic Lab-on-a-Chip
The current high failure rate (more than 50%) of drugs in clinical trials has been linked, in part, to a lack of accurate preclinical testing. This project aims to expand use of Lab-on-a-Chip (a fully automated, multifunctional cell culture platform previously validated in bacterial and crystal growth studies) to study human skeletal muscle cell growth.